Следене
Dennis Lendrem
Dennis Lendrem
Research Associate, Translational & Clinical Research Institute, University of Newcastle upon Tyne
Потвърден имейл адрес: ncl.ac.uk - Начална страница
Заглавие
Позовавания
Позовавания
Година
First experience of COVID-19 screening of health-care workers in England
E Hunter, DA Price, E Murphy, IS van der Loeff, KF Baker, D Lendrem, ...
The Lancet 395 (10234), e77-e78, 2020
3732020
Predation risk and vigilance in the blue tit (Parus caeruleus)
DW Lendrem
Behavioral Ecology and Sociobiology 14, 9-13, 1983
1841983
Health-related utility values of patients with primary Sjögren's syndrome and its predictors
D Lendrem, S Mitchell, P McMeekin, S Bowman, E Price, CT Pease, ...
Annals of the rheumatic diseases 73 (7), 1362-1368, 2014
1252014
Gain‐of‐function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC)
J Zheng, FL van de Veerdonk, KL Crossland, SP Smeekens, CM Chan, ...
European journal of immunology 45 (10), 2834-2846, 2015
1232015
Vigilance and scanning patterns in birds
A Hart, DW Lendrem
Animal Behaviour 32 (4), 1216-1224, 1984
1191984
Sleeping and vigilance in birds. I. Field observations of the mallard (Anas platyrhynchos)
DW Lendrem
Animal Behaviour 31 (2), 532-538, 1983
1171983
Systemic interferon type I and type II signatures in primary Sjögren’s syndrome reveal differences in biological disease activity
ILA Bodewes, S Al-Ali, CG van Helden-Meeuwsen, NI Maria, J Tarn, ...
Rheumatology 57 (5), 921-930, 2018
1142018
Symptom-based stratification of patients with primary Sjögren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised …
JR Tarn, N Howard-Tripp, DW Lendrem, X Mariette, A Saraux, ...
The Lancet Rheumatology 1 (2), e85-e94, 2019
1042019
Sleeping and vigilance in birds, II. An experimental study of the Barbary dove (Streptopelia risoria)
DW Lendrem
Animal Behaviour 32 (1), 243-248, 1984
1001984
Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines
NH Tripp, J Tarn, A Natasari, C Gillespie, S Mitchell, KL Hackett, ...
RMD open 2 (2), e000282, 2016
922016
Impaired functional status in primary Sjögren's syndrome
KL Hackett, JL Newton, J Frith, C Elliott, D Lendrem, H Foggo, S Edgar, ...
Arthritis care & research 64 (11), 1760-1764, 2012
882012
DOE (design of experiments) in development chemistry: Potential obstacles
D Lendrem, M Owen, S Godbert
Organic Process Research & Development 5 (3), 324-327, 2001
882001
Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjögren's syndrome
JL Newton, J Frith, D Powell, K Hackett, K Wilton, S Bowman, E Price, ...
Annals of the rheumatic diseases 71 (12), 1973-1979, 2012
702012
Why is it hard to terminate failing projects in pharmaceutical R&D?
RW Peck, DW Lendrem, I Grant, BC Lendrem, JD Isaacs
Nature reviews Drug discovery 14 (10), 663-664, 2015
632015
Modelling in behavioural ecology: an introductory text
D Lendrem
Springer Science & Business Media, 2012
612012
A transcriptional signature of fatigue derived from patients with primary Sjögren’s syndrome
K James, S Al-Ali, J Tarn, SJ Cockell, CS Gillespie, V Hindmarsh, J Locke, ...
PloS one 10 (12), e0143970, 2015
522015
CD4+ and B lymphocyte expression quantitative traits at rheumatoid arthritis risk loci in patients with untreated early arthritis: implications for causal gene identification
N Thalayasingam, N Nair, AJ Skelton, J Massey, AE Anderson, AD Clark, ...
Arthritis & Rheumatology 70 (3), 361-370, 2018
512018
Pharmacokinetics of the hypoxic cell cytotoxic agent tirapazamine and its major bioreductive metabolites in mice and humans: retrospective analysis of a pharmacokinetically …
MA Graham, S Senan, H Robin Jr, N Eckhardt, D Lendrem, J Hincks, ...
Cancer chemotherapy and pharmacology 40, 1-10, 1997
501997
Predicting drug-free remission in rheumatoid arthritis: a prospective interventional cohort study
KF Baker, AJ Skelton, DW Lendrem, A Scadeng, B Thompson, AG Pratt, ...
Journal of autoimmunity 105, 102298, 2019
492019
The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapy
FAH Cooles, AE Anderson, DW Lendrem, J Norris, AG Pratt, CMU Hilkens, ...
Journal of Allergy and Clinical Immunology 141 (1), 445-448. e4, 2018
492018
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20